SCHEMBL3408238

SCHEMBL3408238

CC(Nc1nc(N)nc(-c2ccc(CC(N)C(=O)O)cc2)n1)c1ccc2ccccc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TPH1 P17752 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14969126 1.00 TPH1 (1.00) TPH1
SCHEMBL14969125 1.00 TPH1 (1.00) TPH1
SCHEMBL308509 1.00 TPH1 (1.00) TPH1
SCHEMBL308510 1.00 TPH1 (1.00) TPH1
SCHEMBL3409703 0.91 TPH1 (0.83) TPH1
SCHEMBL307877 0.91 TPH1 (0.83) TPH1
SCHEMBL12694100 0.88 TPH1 (0.78) TPH1
SCHEMBL307612 0.87 TPH1 (1.00) TPH1
SCHEMBL322334 0.87 TPH1 (1.00) TPH1
SCHEMBL307611 0.87 TPH1 (1.00) TPH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101351451-A Polycyclic amino acid derivatives and methods of use thereof LEXICON GENETICS INC (US) 2009-01-21 CN claimed
CN-103265495-A Multicyclic amino acid derivatives and methods of their use LEXICON GENETICS INC 2013-08-28 CN disclosed
CN-101351451-B Polycyclic amino acid derivatives and methods of use thereof LEXICON PHARMACEUTICALS INC 2013-02-20 CN disclosed
CN-102753168-A Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease LEXICON PHARMACEUTICALS INC 2012-10-24 CN disclosed
CN-102711757-A Methods and assays for treating irritable bowel syndrome LEXICON PHARMACEUTICALS INC 2012-10-03 CN disclosed
CN-102083454-A Methods for diagnosing, preventing and treating bone mass disorders UNIV COLUMBIA 2011-06-01 CN disclosed
CN-101969952-A Compositions comprising tryptophan hydroxylase inhibitors LEXICON PHARMACEUTICALS INC 2011-02-09 CN disclosed
CN-101815534-A methods and compositions for treating pulmonary hypertension and related diseases and disorders LEXICON PHARMACEUTICALS INC 2010-08-25 CN disclosed
CN-101801385-A Methods of affecting gastrointestinal transit and gastric emptying, and compounds useful therein LEXICON PHARMACEUTICALS INC 2010-08-11 CN disclosed
CN-101784269-A methods of treating serotonin-mediated diseases and disorders LEXICON PHARMACEUTICALS INC 2010-07-21 CN disclosed
WO-2010062829-A1 TRYPTOPHAN HYDROXYLASE INHIBITORS FOR TREATING OSTEOPOROSIS LEXICON PHARMACEUTICALS, INC. (US) 2010-06-03 WO disclosed
EP-2178536-A1 METHODS OF AFFECTING GASTROINTESTINAL TRANSIT AND GASTRIC EMPTYING, AND COMPOUNDS USEFUL THEREIN Lexicon Pharmaceuticals, Inc. (US) 2010-04-28 EP disclosed
EP-2170335-A1 COMPOSITIONS COMPRISING TRYPTOPHAN HYDROXYLASE INHIBITORS Lexicon Pharmaceuticals, Inc. (US) 2010-04-07 EP disclosed
EP-2170306-A1 METHODS OF TREATING SEROTONIN-MEDIATED DISEASES AND DISORDERS Lexicon Pharmaceuticals, Inc. (US) 2010-04-07 EP disclosed
EP-2170397-A1 METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION AND RELATED DISEASES AND DISORDERS Lexicon Pharmaceuticals, Inc. (US) 2010-04-07 EP disclosed
WO-2009014972-A1 METHODS OF AFFECTING GASTROINTESTINAL TRANSIT AND GASTRIC EMPTYING, AND COMPOUNDS USEFUL THEREIN LEXICON PHARMACEUTICALS, INC. (US) 2009-01-29 WO disclosed
CN-101351451-A Polycyclic amino acid derivatives and methods of use thereof LEXICON GENETICS INC (US) 2009-01-21 CN disclosed
WO-2009009561-A1 METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION AND RELATED DISEASES AND DISORDERS LEXICON PHARMACEUTICALS, INC. (US) 2009-01-15 WO disclosed
WO-2009002970-A1 COMPOSITIONS COMPRISING TRYPTOPHAN HYDROXYLASE INHIBITORS LEXICON PHARMACEUTICALS, INC. (US) 2008-12-31 WO disclosed
WO-2009002964-A1 METHODS OF TREATING SEROTONIN-MEDIATED DISEASES AND DISORDERS LEXICON PHARMACEUTICALS, INC. (US) 2008-12-31 WO disclosed